Gastroretentive montmorillonite-tetracycline nanoclay for the treatment of Helicobacter pylori infection
- 1 September 2015
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 493 (1-2) , 295-304
Abstract
No abstract availableKeywords
Funding Information
- MIUR
This publication has 45 references indexed in Scilit:
- Lectin-conjugated microspheres for eradication of Helicobacter pylori infection and interaction with mucusInternational Journal of Pharmaceutics, 2014
- Interstratification Patterns from the pH-Dependent Intercalation of a Tetracycline Antibiotic within Montmorillonite LayersLangmuir, 2013
- Toxicological effects of a cationic clay, montmorillonite in vitro and in vivoMolecular & Cellular Toxicology, 2012
- Sorption of Sulfonamides and Tetracyclines to Montmorillonite ClayWater, Air, & Soil Pollution, 2009
- Adsorption and intercalation of tetracycline by swelling clay mineralsApplied Clay Science, 2009
- Gastroretentive dosage forms: Overview and special case of Helicobacter pyloriJournal of Controlled Release, 2006
- Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugsBiomaterials, 2005
- Influence of dispersion conditions of two pharmaceutical grade clays on their interaction with some tetracyclinesApplied Clay Science, 2005
- Acid–base equilibria of tetracycline in sodium montmorillonite suspensionsJournal of Pharmaceutical Sciences, 1980
- Mucus and bicarbonate secretion in the stomach and their possible role in mucosal protection.Gut, 1980